Investigation the Effect of the Social-Communication Area Developmental Screening Test for Infants and Young Children Training Program Applied in Addition to the DIR/Floortime™ Therapy Program in Children with Developmental Risk
NCT ID: NCT06345170
Last Updated: 2025-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2022-10-30
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring the Feasibility and Preliminary Efficacy of Therapeutic Playgroups in Early Intervention
NCT03062371
A Pilot Trial of a Developmental, Individual-Difference, Relationship-Bases (DIR)/Floortime for Children With Autistic Spectrum Disorders
NCT00954083
A Study of a Developmental,Individual-Difference,Relationship-Bases/Floortime Intervention for Children With Autistic
NCT00954213
Early Intervention in Children at Risk of Developmental Delay
NCT06052410
Effects of a Short-term Parent Mediated Social Training on Developmental Trajectories in Infants
NCT03404505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The group in which the Social-Communication Area Developmental Screening Test for Infants and Young Children (SCASI) training program will be applied in addition to the DIR/Floortime™ therapy program
The DIR/Floortime™ Therapy Program
The DIR/Floortime™ therapy program will be applied by the therapist in the clinic for 50 minutes, 2 days a week for 12 weeks
The Social-Communication Area Developmental Screening Test for Infants and Young Children (SCASI) Training Program
The Social-Communication Area Developmental Screening Test for Infants and Young Children (SCASI) Training Program will be applied by the parents at home, 2 days a week, for an average of 30 minutes a day, for 12 weeks
Control Group
The group in which the DIR/Floortime™ therapy program will be applied
The DIR/Floortime™ Therapy Program
The DIR/Floortime™ therapy program will be applied by the therapist in the clinic for 50 minutes, 2 days a week for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The DIR/Floortime™ Therapy Program
The DIR/Floortime™ therapy program will be applied by the therapist in the clinic for 50 minutes, 2 days a week for 12 weeks
The Social-Communication Area Developmental Screening Test for Infants and Young Children (SCASI) Training Program
The Social-Communication Area Developmental Screening Test for Infants and Young Children (SCASI) Training Program will be applied by the parents at home, 2 days a week, for an average of 30 minutes a day, for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The language of the parents and the child is Turkish
* Assessment of SİATT pre-test result as "developmental risk"
* Parents' willingness to participate in the study
Exclusion Criteria
* Illiteracy of parents
* The child has orthopedic, neurological disability(s) other than developmental risk
1 Year
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biruni University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hikmet Ucgun
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biruni University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
buhucgun05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.